A

Andlauer Healthcare Group Inc
TSX:AND

Watchlist Manager
Andlauer Healthcare Group Inc
TSX:AND
Watchlist
Price: 53.22 CAD -0.34% Market Closed
Market Cap: 2.1B CAD

EV/EBITDA
Enterprise Value to EBITDA

12.9
Current
10.9
Median
11.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
12.9
=
Enterprise Value
2.1B CAD
/
EBITDA
165m CAD

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
12.4
2-Years Forward
EV/EBITDA
11.6
3-Years Forward
EV/EBITDA
11.4